ELVN Enliven Therapeutics
- 24.990
- +0.565+2.31%
Enliven Therapeutics News
Enliven Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hohl Benjamin
Enliven Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Enliven Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Enliven Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hohl Benjamin
Enliven Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Enliven Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Enliven Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(2.2%),Peter Kolchinsky(2.2%), etc.
Enliven Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Venrock Healthcare Capital Partners III, L.P.(8.5%),VHCP Co-Investment Holdings III, LLC(8.5%), etc.
Enliven Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Citadel Advisors LLC(3.7%),Citadel Advisors Holdings LP(3.7%), etc.
Enliven Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Fairmount Funds Management LLC(6.8%),Peter Harwin(6.8%), etc.
Enliven Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Commodore Capital LP(8.7%),Commodore Capital Master LP(8.7%)
Enliven Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Polar Capital Holdings Plc(5.69%),Polar Capital LLP(5.69%)
Enliven Therapeutics | 10-Q: Q3 2024 Earnings Report
Enliven Therapeutics | 8-K: Enliven Therapeutics Reports Third Quarter Financial Results and Provides a Business Update
Enliven Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(6.2%)
Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hohl Benjamin
Enliven Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(6.2%)
Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Patel Anish
No Data